cerning a case of melioidosis in chronic granulomatous disease.
of severe melioidosis: a randomized, double-blind, controlled study. J
We would like to comment on the therapeutic regimens used in Med Assoc Thai 1998; 81:265 -71. this case. alone [3] , or ceftazidime plus trimethoprim-sulfamethoxazole Clinical Infectious Diseases 1999; 28:410 (TMP-SMZ) [4] , with a combination of chloramphenicol, doxycy- reported the predictably high incidence of CAP due to StreptococThe combination of imipenem and doxycycline as therapy for cus pneumoniae and Haemophilus influenzae in patients with HIV. melioidosis has never been the subject of clinical investigation.
However, the authors reported a single case of Staphylococcus Doxycycline has been shown to antagonize the cidal action of aureus-related CAP and six cases of CAP due to Pseudomonas ceftazidime against Burkholderia pseudomallei in vitro [7] , and it aeruginosa in HIV-infected patients. The report does not clearly is possible that doxycycline may antagonize imipenem. We recomindicate how these cases were diagnosed, but the table suggests mend caution in the use of untested, potentially antagonistic regithat specimens were obtained bronchoscopically, although a semimens in treatment of a disease associated with high mortality and quantitative protected specimen brush (PSB) technique was not relapse rates. This same point applies to the combination of oral used. Interpretation of the data is difficult because demographic cefixime and doxycycline used for maintenance treatment in this data on these patients are not provided (e.g., prior antibiotic therapy case.
might have selected out P. aeruginosa and P. aeruginosa colonized the lower respiratory tract [2] [3] [4] [5] [6] [7] . Bacteremic CAPs due to S. pneumoniae and H. influenzae Bangkok, Thailand; and Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom should alert clinicians to the possibility of HIV infection. Because HIV infection results in decreased cell-mediated immunity, it is not surprising that in addition to the usual respiratory pathogens
